Insight Molecular Diagnostics (IMDX) EBT Margin Growth (3y) (2023 - 2026)
Insight Molecular Diagnostics (IMDX) EBT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -211.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 3,356.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 28.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -317.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 399.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 3,000.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 135.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 360.00 |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | -297,093.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -297,093.00 |
| Mar 31, 2026 | -3.04 Mn |
| Dec 31, 2025 | -64,208.00 |
| Sep 30, 2025 | -405,786.00 |
| Jun 30, 2025 | -182,546.00 |
| Mar 31, 2025 | 891.00 |
| Dec 31, 2024 | -126,576.00 |
| Sep 30, 2024 | -1.03 Mn |
| Jun 30, 2024 | -415,531.00 |
| Mar 31, 2024 | -416,531.00 |
| Dec 31, 2023 | -380,711.00 |
| Sep 30, 2023 | -29,043.00 |
| Jun 30, 2023 | 456,945.00 |
| Mar 31, 2023 | 5.72 Mn |